Menu

Advisory Board

Professor Bong J. Walsh

Bong J. Walsh, Ph.D. is Professor of Cognitive Psychology and Neuroscience, a Human Factors Consultant, and Expert Witness and Forensic Consultant at Boster, Kobayashi & Associates.

Bong is Adjunct Professor at the California School of Professional Psychology at Alliant University in Los Angeles. He is developing curriculum and teaching online videoconferenced sections of Cognitive and Affective Bases of Behavior. Topics include perception, attention, memory, decision-making, language processing, effects of emotion on cognitive processes, and effects of stress and physiological state on cognitive and emotional processes.

At Boster, Kobayashi & Associates, Bong deals with Human Factors (perception, attention, information processing, decision making, memory, reaction time, cognitive biases), psychopharmacology, and accident reconstruction. He joined them in 2017.

Bong is the Founder and Director of Better Brains for Life. Founded in 2016, it is a personalized comprehensive program designed to help adults achieve and maintain optimal brain health, cognitive function, and emotional wellness.

Previously, he was Associate Professor at American School of Professional Psychology for almost 5 years where he taught Physiological Psychology, Neuroscientific Bases of Psychological Disorders, Cognition & Affective Processes, Research Methods, Statistics, Clinical Psychopharmacology, and Clinical Research Project (CRP) Development.

Bong earned his Bachelor’s degree of Science in Biopsychology from the University of California in Santa Barbara in 1994. He became Research Assistant where, for 2 years, he did gene therapy work including animal microsurgery, tissue extraction, gene expression analysis, and DNA sequencing. Bong coauthored three research articles at that time.

In 1997, he became Instructor at the Upward Bound federally-funded program, where he taught SAT preparation, biology, chemistry, and mathematics to underserved inner-city high school students.

In 1998, Bong joined Metabolex (now known as CymaBay), a biotechnology (diabetes) company, where he did hands-on laboratory research including identifying a novel gene product that later became one of the company’s first compounds in clinical trials. Responsibilities included cloning, gene expression analysis, calcium imaging, and many other cell, molecular, and biochemical techniques.

In 2002, Bong decided to pursue a doctorate at the University of California in Davis. In 2008, he earned his Ph.D. in Cognitive Neuroscience. In a Magnum Lab at UC Davis, he designed, ran, and analyzed experiments testing human attention, arousal, cognitive control, and performance. These experiments involved fMRI, EEG, eye-tracking, and big data analysis using Matlab. He created a novel analysis that showed how cognitive conflict levels could be predictive of future adjustments in attention, with this work published in the Journal of Cognitive Neuroscience.

His Post-doctoral Research was done at the Cognitive Psychology/Neuroscience lab, Center for Mind & Brain at the University of California, Davis. There he also coauthored a chapter in a Cognitive Neuroscience anthology and assisted in submitting a successfully NIH-funded research grant.

In 2009, for three years, he became Lecturer and Instructor of Cognitive Psychology and Cognitive Neuroscience to UC Davis undergraduate psychology students. In 2011, he then moved to the American School of Professional Psychology.

Read his articles Non-Verbal Paradigm for Assessing Individuals for Absolute Pitch, Green fluorescent protein as a reporter for gene transfer studies in the cochlea, TBC domain family, member 15 is a novel mammalian Rab GTPase-activating protein with substrate preference for Rab7, and Integrating conflict detection and attentional control mechanisms which can also be found in the textbook The Cognitive Neuroscience from the MIT Press and the Journal of Cognitive Neuroscience.

View and read his detailed curriculum vitae at BKA.

Visit his LinkedIn profile. Follow him on Facebook, Instagram, and Twitter.